Removal of pharmaceutical residue in municipal wastewater by DAF (dissolved air flotation)-MBR (membrane bioreactor) and ozone oxidation

Growing attention is given to pharmaceutical residue in the water environment. It is known that pharmaceuticals are able to survive from a series of wastewater treatment processes. Concerns regarding pharmaceutical residues are attributed to the fact that they are being detected in water and sedimen...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Water science and technology : a journal of the International Association on Water Pollution Research. - 1986. - 66(2012), 12 vom: 07., Seite 2546-55
1. Verfasser: Choi, Miyoung (VerfasserIn)
Weitere Verfasser: Choi, Dong Whan, Lee, Jung Yeol, Kim, Young Suk, Kim, Bun Su, Lee, Byoung Ho
Format: Online-Aufsatz
Sprache:English
Veröffentlicht: 2012
Zugriff auf das übergeordnete Werk:Water science and technology : a journal of the International Association on Water Pollution Research
Schlagworte:Journal Article Membranes, Artificial Waste Water Water Pollutants, Chemical Ozone 66H7ZZK23N
LEADER 01000naa a22002652 4500
001 NLM222214821
003 DE-627
005 20231224053740.0
007 cr uuu---uuuuu
008 231224s2012 xx |||||o 00| ||eng c
024 7 |a 10.2166/wst.2012.429  |2 doi 
028 5 2 |a pubmed24n0740.xml 
035 |a (DE-627)NLM222214821 
035 |a (NLM)23109569 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Choi, Miyoung  |e verfasserin  |4 aut 
245 1 0 |a Removal of pharmaceutical residue in municipal wastewater by DAF (dissolved air flotation)-MBR (membrane bioreactor) and ozone oxidation 
264 1 |c 2012 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Completed 04.03.2013 
500 |a Date Revised 07.12.2022 
500 |a published: Print 
500 |a Citation Status MEDLINE 
520 |a Growing attention is given to pharmaceutical residue in the water environment. It is known that pharmaceuticals are able to survive from a series of wastewater treatment processes. Concerns regarding pharmaceutical residues are attributed to the fact that they are being detected in water and sediment environment ubiquitously. Pharmaceutical treatment using a series of wastewater treatment processes of the DAF (dissolved air flotation)-MBR (membrane bioreactor)-ozone oxidation was conducted in the study. DAF, without addition of coagulant, could remove COD(cr) (chemical oxygen demand by Cr) up to over 70%, BOD 73%, SS 83%, T-N 55%, NH₄(+) 23%, and T-P 65% in influent of municipal wastewater. Average removal rates of water quality parameters by the DAF-MBR system were very high, e.g. COD(cr) 95.88%, BOD₅ 99.66%, COD(mn) (chemical oxygen demand by Mn) 93.63%, T-N 69.75%, NH₄-N 98.46%, T-P 78.23%, and SS 99.51%, which satisfy effluent water quality standards. Despite the high removal rate of the wastewater treatment system, pharmaceuticals were eliminated to be about 50-99% by the MBR system, depending on specific pharmaceuticals. Ibuprofen was well removed by MBR system up to over 95%, while removal rate of bezafibrate ranged between 50 and 90%. With over 5 mg/l of ozone oxidation, most pharmaceuticals which survived the DAF-MBR process were removed completely or resulted in very low survival rate within the range of few micrograms per litre. However, some pharmaceuticals such as bezafibrate and naproxen tended to be resistant to ozone oxidation 
650 4 |a Journal Article 
650 7 |a Membranes, Artificial  |2 NLM 
650 7 |a Waste Water  |2 NLM 
650 7 |a Water Pollutants, Chemical  |2 NLM 
650 7 |a Ozone  |2 NLM 
650 7 |a 66H7ZZK23N  |2 NLM 
700 1 |a Choi, Dong Whan  |e verfasserin  |4 aut 
700 1 |a Lee, Jung Yeol  |e verfasserin  |4 aut 
700 1 |a Kim, Young Suk  |e verfasserin  |4 aut 
700 1 |a Kim, Bun Su  |e verfasserin  |4 aut 
700 1 |a Lee, Byoung Ho  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Water science and technology : a journal of the International Association on Water Pollution Research  |d 1986  |g 66(2012), 12 vom: 07., Seite 2546-55  |w (DE-627)NLM098149431  |x 0273-1223  |7 nnns 
773 1 8 |g volume:66  |g year:2012  |g number:12  |g day:07  |g pages:2546-55 
856 4 0 |u http://dx.doi.org/10.2166/wst.2012.429  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 66  |j 2012  |e 12  |b 07  |h 2546-55